【Brief News】Shenzhen Cell Valley Invited to Attend Southern Medical University Pingshan Hospital and Biopharmaceutical Enterprise Cooperation Exchange Meeting

Date:08-23  Hits:  Belong to:News

图片.png

On August 22, Shenzhen Cell Valley was honored to be invited to participate in the "Hospital-Enterprise Hand in Hand, Two-Way Empowerment" Biopharmaceutical Enterprise Cooperation Exchange Meeting hosted by Southern Medical University Pingshan Hospital. The meeting was attended by hospital leadership from Southern Medical University Pingshan Hospital, along with Deputy Director Yuan Shuai of the Science, Techno

logy and Innovation Bureau, multiple outstanding biopharmaceutical enterprises within the district, and authoritative experts and scholars from both within and outside the district. The gathering brought together talented individuals to focus on disciplinary frontiers and jointly discuss academic development. Our Marketing Department Sales Manager Wu Xiaosheng and Director of the General Administration Office Wang Lu attended the meeting as company representatives.

图片.png

During the exchange session, Manager Wu Xiaosheng provided a detailed introduction to Shenzhen Cell Valley from multiple perspectives, including the current state of the cell therapy industry, the company's core technologies, the founding team, the core R&D and production team, recent research achievements, and clinical application cases. Shenzhen Cell Valley has achieved multiple breakthrough advancements in the cell therapy field, particularly in the production and preparation of non-genetically modified cells. The company has successfully achieved industrial-scale production of allogeneic natural killer (NK) cell therapy products and has successfully applied this technology in clinical practice.

At this exchange meeting, the participating leaders and experts gained a deeper understanding of Shenzhen Cell Valley and expressed strong confidence in the company's professional capabilities in the cell therapy field and its future development. They also firmly believe that under the guidance and support of the Pingshan District Government, hospitals and enterprises within the district will join hands to jointly advance the development of healthcare and provide higher-quality medical services to the public.

(Group photo)

图片.png


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@sz-cell.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Shenzhen Cell Valley Biopharmaceutical Co., Ltd. is a leading one-stop comprehensive outsourcing service provider for China’s cell and gene therapy industry. It is also among the first domestic CRO/CDMO enterprises to hold GMP-compliant industrial production capabilities for clinical-grade retroviral vectors. As a key project for the construction of Shenzhen’s public technical service platform for CRO/CDMO, the company has been listed in the city’s newly announced "20+8" strategic emerging industries initiative.
Shenzhen Cell Valley is equipped with the capacity to conduct standardized and industrialized production of GMP-grade cellular products including CAR-T cells. Its core production lines cover a full spectrum of cellular products such as CAR-T, CAR-NK, CAR-M, γδT, TIL and TCR-T. In addition, the company runs production lines for a diverse range of viral vectors (including RVV, LVV and AAV) and non-viral vectors, as well as for cellular raw materials for therapeutic development—such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses and vaccines.